Research Library

Clinical flat lay comparing injectable semaglutide (Ozempic) and oral 5-Amino-1MQ NNMT inhibitor capsule — GLP-1 vs NNMT mechanism comparison for UK metabolic researchers
5-Amino-1MQ vs Ozempic: What Researchers Are Actually Comparing
Ozempic (semaglutide) and 5-Amino-1MQ are both being discussed in metabolic research circles — but they work through completely different mechanisms. This article explains the science behind each, why researchers are... Read more...
5-Amino-1MQ 50mg research-grade supplement capsule on a clean clinical background with NNMT molecular structure
5-Amino-1MQ Dosage: What the Research Says
A research-backed look at 5-Amino-1MQ dosing — what studies have used, cycling protocols, and why 50mg is the standard reference dose. Read more...
Comparison of injectable peptide vials and oral capsules for research compound protocols — BPC-157, TB-500 vs 5-Amino-1MQ oral NNMT inhibitor
Why Serious Researchers Are Ditching Peptide Injections for Oral Compounds
Peptide injections dominated the research compound space for years. BPC-157, TB-500, Semaglutide analogues — all requiring reconstitution, cold storage, and precise injection protocols. In 2026, a growing number of UK... Read more...
NNMT inhibitor buyer's guide — research-grade 5-Amino-1MQ capsule UK sourcing
NNMT Inhibitor Buyer's Guide: What to Look For (and What to Avoid)
Buying an NNMT inhibitor in the UK? The market is growing fast — and quality control is not keeping up. This guide covers the 5 things that separate research-grade from... Read more...
5-Amino-1MQ NNMT inhibitor molecular structure — research-grade compound UK
5-Amino-1MQ: The NNMT Inhibitor Redefining Metabolic Research in 2026
Buy 5-Amino-1MQ UK — the research-grade NNMT inhibitor serious buyers are sourcing in 2026. Oral bioavailability, clean label, accurately dosed at 50mg. How it works, how it compares to BPC-157... Read more...